The fund replicates the MSCI Switzerland 25/50 Index and covers most of the market capitalization of the Swiss equity market. To prevent any single holding from becoming overweight, it applies a capping methodology (Cap) and aims for a stable portfolio structure.

It suits long-term investors who want to increase their allocation to blue-chip Swiss stocks, backed by one of Europe's most stable economic structures, as part of global asset allocation.

It is a passively managed (index-tracking) ETF launched by BlackRock in 1996.

The portfolio is built around the largest Swiss-listed companies by market capitalization, with particularly high weightings in healthcare, financial, and consumer staples companies that are active in global markets. The index's own diversification rules help manage single-stock risk while the fund tracks performance.

• Provides broad and transparent exposure to the Swiss market
• Offers top-tier liquidity and a long operating history among single-country ETFs

Assets under management (AUM) stand at $3.0B, and the expense ratio (Expense Ratio) is 0.50% per year.

Compared with similar European country ETFs such as EWG (Germany) and EWU (United Kingdom), it carries higher weightings in healthcare and food sectors, giving it a relatively more defensive character.

During periods of rising global economic volatility, the solid fundamentals of Swiss companies came into focus and the fund showed a stable trajectory, while new drug development achievements at major pharmaceutical companies have had a positive effect on returns.

Demand for the Swiss stock market, which has strong safe-haven characteristics even among European assets, remains steady, and inflows aimed at building defensive portfolios stand out when market uncertainty is high.

The fund offers an efficient way to invest in blue-chip Swiss stocks with world-renowned brand power, but investors should be wary of sector concentration and currency volatility.

EWC, EWU, and EWP shown in the table are country-specific products that invest in other developed markets such as Canada, the United Kingdom, and Spain, respectively. If you want to invest across developed markets in general, including Switzerland, VEA is an excellent alternative, and if you want broader exposure to Europe as a whole, it is worth considering VGK or IEV as well. If you prioritize dividend growth, VIGI, a European dividend stock ETF, can also be a good option.

Here is a key checklist to review before investing in the iShares MSCI Switzerland ETF (EWL). It is important to analyze the Swiss market's distinctive economic characteristics and sector weightings closely before making an investment decision.

The Swiss stock market has high weightings in large pharmaceutical and financial companies, so it can react sensitively to issues in specific industries. In addition, although the fund has a defensive character even during a global economic slowdown, investors should note that currency fluctuations can offset returns.

It is a standard vehicle for investing in the high-quality companies of Switzerland, a core developed economy in Europe. It is a suitable asset for investors who want to build a global portfolio with a defensive character.